Clinical trials for breast cancer

80 currently recruiting clinical trials

Phase 2 Breast cancer
#NCT05800275
HER2 Positive Metastatic 1 2 3 or more
Centre François Baclesse (Caen ), Institut Godinot (Reims), Centre Jean Perrin (Clermont Ferrand ), Centre Léon Bérard (Lyon), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ) (and 5 more...)
UNICANCER
Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer
#NCT05732831
Locally Advanced Metastatic Metastatic Castration-resistant MTAP 1 2 3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Tango Therapeutics
Phase 2 Breast cancer
#NCT05625087
HER2 Negative HR Positive Metastatic PIK3CA 1 Hormone therapy Systemic Treatment-Naive
Centre Hospitalier de la Côte Basque (Bayonne), CHU Amiens-Picardie (Amiens), Clinique de l'Europe d'Amiens (Amiens), Centre Hospitalier d’Auxerre (Auxerre), Institut Sainte Catherine (Avignon) (and 34 more...)
UNICANCER
Phase 2 Breast cancer
#NCT05563220
HER2 Negative HR Positive Locally Advanced Metastatic 1 2 Hormone therapy
Chemotherapy
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre de Cancérologie du Grand Montpellier (Montpellier), Centre Hospitalier Universitaire de Toulouse (Toulouse), Gustave Roussy (Villejuif), Centre Henri Becquerel (Rouen )
Stemline Therapeutics, Inc.
Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer
#NCT05384626
Locally Advanced Metastatic Metastatic Castration-resistant ALK 1 2 3 or more
AKT ATM BRAF BRCA 1/2 CDK12 CHEK 1/2 ESR FGFR HER2 HOXB13 KRAS G12C KRAS non G12C MET MSI/dMMR NRAS NTRK-1/2/3 PALB2 PIK3CA PTEN RET Systemic Treatment-Naive
Gustave Roussy (Villejuif), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Nuvalent Inc.
Phase 2 Breast cancer
#NCT05297617
HER2 Negative HR Positive Localized None Surgery Hormone therapy
Chemotherapy
Clinique des Cèdres - Ramsay Santé (Cornebarrieu), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Clinique Chénieux (Limoges), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital NOVO (Site de Pontoise) (Pontoise) (and 42 more...)
UNICANCER
Phase 2 Breast cancer
#NCT05215106
HER2 Negative HR Negative Localized None Systemic Treatment-Naive
Surgery Immunotherapy Chemotherapy Targeted therapy Car-T Bispecific T-cell engager antibodies Antibody Drug Conjugates (ADC) Radiotherapy
Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 2 Breast cancer
#NCT04985266
HER2 Negative HR Positive Localized None Surgery Chemotherapy Hormone therapy
Targeted therapy
Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne (CHU Saint-Étienne) (Saint-Priest-en-Jarez), Institut Bergonié (Bordeaux), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy), Centre Hospitalier de Blois (Blois) (and 15 more...)
Fiducie de la Fondation Royal Marsden NHS
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Pancreas cancer
#NCT04924075
Locally Advanced Metastatic Other mutation 1
Systemic Treatment-Naive
Hôpital Bicêtre AP-HP (Le Kremlin-Bicêtre), Hôpital Cochin (Paris ), Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg (Strasbourg), Gustave Roussy (Villejuif), Hôpital Edouard Herriot - Hospices Civils de Lyon (Lyon)
Merck Sharp & Dohme LLC
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer
#NCT04116541
Locally Advanced Metastatic Metastatic Castration-resistant ALK BRAF EGFR FGFR MET NTRK-1/2/3 RET ROS-1 SMAD4 Other mutation 1 2 3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), IUCT Oncopôle (Toulouse), Institut Paoli-Calmettes (Marseille), Gustave Roussy (Villejuif), Centre Antoine Lacassagne (Nice) (and 2 more...)
Centre Léon Bérard